• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers.

作者信息

Thalheimer Ulrich, Bosch Jaime, Burroughs Andrew K

机构信息

Liver Transplantation and Hepatobiliary Unit, Royal Free Hospital, London, United Kingdom.

出版信息

Gastroenterology. 2007 Dec;133(6):2029-36. doi: 10.1053/j.gastro.2007.10.028. Epub 2007 Oct 22.

DOI:10.1053/j.gastro.2007.10.028
PMID:18054573
Abstract
摘要

相似文献

1
How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers.如何预防静脉曲张出血：灰色地带——非选择性β受体阻滞剂的情况
Gastroenterology. 2007 Dec;133(6):2029-36. doi: 10.1053/j.gastro.2007.10.028. Epub 2007 Oct 22.
2
Blind beta blockade.盲目β受体阻滞剂治疗
Hepatology. 2001 Oct;34(4 Pt 1):847-8. doi: 10.1002/hep.510340434.
3
Beta-blocker plus nitrate for primary prophylaxis of variceal bleeding.
Gastroenterology. 2000 Oct;119(4):1170-2. doi: 10.1016/s0016-5085(00)80037-2.
4
[Beta blocker prevention of hemorrhages from esophageal varices in liver cirrhosis].[β受体阻滞剂预防肝硬化食管静脉曲张出血]
Dtsch Med Wochenschr. 1983 Apr 8;108(14):549-51. doi: 10.1055/s-2008-1069595.
5
Beta-blockers in prevention of variceal hemorrhage: tantalizing expectations.
Am J Gastroenterol. 1992 Feb;87(2):253-5.
6
Propranolol or sclerotherapy to prevent variceal rebleeding.
Natl Med J India. 1995 Sep-Oct;8(5):222.
7
[Esophageal varices. Drug treatment of recurrent bleeding and its prevention: beta blockers].
Praxis (Bern 1994). 1995 Dec 19;84(51-52):1544.
8
[Can beta blockers prevent gastrointestinal bleeding from varices in cirrhotic patients?].β受体阻滞剂能否预防肝硬化患者静脉曲张引起的胃肠道出血？
Schweiz Rundsch Med Prax. 1984 Jun 26;73(26):815-6.
9
The role of nonselective beta-blockers in the prevention of gastric variceal rebleeding.
Endoscopy. 2008 Feb;40(2):168; author reply 168. doi: 10.1055/s-2007-995423.
10
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series.利拉鲁肽对β受体阻滞剂预防静脉曲张出血的作用：病例系列
Ann Intern Med. 2020 Sep 1;173(5):404-405. doi: 10.7326/L20-0041. Epub 2020 May 26.

引用本文的文献

1
The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension.普萘洛尔对肝硬化伴显著门脉高压患者胃肠动力和通透性的影响。
BMC Gastroenterol. 2024 Nov 21;24(1):420. doi: 10.1186/s12876-024-03483-6.
2
Hepatic immune regulation and sex disparities.肝脏免疫调节与性别差异。
Nat Rev Gastroenterol Hepatol. 2024 Dec;21(12):869-884. doi: 10.1038/s41575-024-00974-5. Epub 2024 Sep 5.
3
Carvedilol for prevention of variceal bleeding: a systematic review and meta-analysis.
卡维地洛预防静脉曲张出血：一项系统评价与荟萃分析
Ann Gastroenterol. 2019 May-Jun;32(3):287-297. doi: 10.20524/aog.2019.0368. Epub 2019 Mar 12.
4
Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.卡维地洛与传统非选择性β受体阻滞剂用于肝硬化合并食管胃静脉曲张的成人患者比较
Cochrane Database Syst Rev. 2018 Oct 29;10(10):CD011510. doi: 10.1002/14651858.CD011510.pub2.
5
Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension.肝硬化门静脉高压症治疗靶点的优先排序和试验设计。
Hepatology. 2019 Mar;69(3):1287-1299. doi: 10.1002/hep.30314. Epub 2019 Feb 9.
6
Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study.利福昔明与普萘洛尔联合治疗降低门静脉压力的疗效优于普萘洛尔单药治疗：一项开放随机对照的初步研究。
Gut Liver. 2017 Sep 15;11(5):702-710. doi: 10.5009/gnl16478.
7
Pediatric gastrointestinal bleeding: Perspectives from the Italian Society of Pediatric Gastroenterology.小儿胃肠道出血：来自意大利小儿胃肠病学会的观点
World J Gastroenterol. 2017 Feb 28;23(8):1328-1337. doi: 10.3748/wjg.v23.i8.1328.
8
Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function.
BMJ Open Gastroenterol. 2016 Dec 9;3(1):e000104. doi: 10.1136/bmjgast-2016-000104. eCollection 2016.
9
Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension.重新审视非选择性β受体阻滞剂在肝硬化和门静脉高压患者中的作用。
World J Hepatol. 2016 Aug 28;8(24):1012-8. doi: 10.4254/wjh.v8.i24.1012.
10
Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement.肝硬化与门静脉高压：风险分层的重要性，肝静脉压力梯度测量的作用
World J Hepatol. 2015 Apr 8;7(4):688-95. doi: 10.4254/wjh.v7.i4.688.